A single nucleotide polymorphism in PIK3CA gene is inversely associated with P53 protein expression in breast cancer

被引:9
作者
Pang, Bo [1 ]
Sun, Shi-Peng [1 ]
Gao, Lei [1 ]
Zhu, Rui-Li [2 ]
Zhang, Li-xin [3 ]
An, Cheng [1 ]
Liu, Zhi-Yuan [1 ]
Liu, Gui-Jian [1 ]
机构
[1] China Acad Chinese Med Sci, Clin Lab, Guanganmen Hosp, Beijing 100053, Peoples R China
[2] China Acad Chinese Med Sci, Clin Lab, Guanganmen South Area Hosp, Beijing 102618, Peoples R China
[3] Anyang Tumor Hosp, Anyang 455000, Henan Province, Peoples R China
关键词
Breast cancer; Single nucleotide polymorphism; p53; Alpha catalytic subunit of phosphoinositol-3-kinase; PROGNOSTIC VALUE; OVARIAN-CANCER; ACCUMULATION; CARCINOMAS; MUTATIONS; TAMOXIFEN; RISK; RESISTANCE; ONCOGENE; SURVIVAL;
D O I
10.1007/s12032-014-0030-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Single nucleotide polymorphism (SNP) rs17849071 was recently reported to be inversely associated with PIK3CA amplification in follicular thyroid cancer, but the main function of this SNP remains unclear. In this study, by using PCR and sequencing method, we explored whether this SNP was associated with P53 expression status and other clinicopathological characteristics in 62 Chinese breast cancer (BCa) patients. In our results, P53 protein accumulation was significantly associated with HER2 overexpression (P = 0.013) and Ki-67 expression (P = 0.007), which were in accord with previous studies. Besides, there was a significantly inverse relationship between P53 protein expression and rs17849071 GT+GG genotype in Chinese BCa patients (P = 0.044). The SNP was not related to other important BCa markers such as estrogen receptor, progestin receptor, and HER2. Among different BCa intrinsic subtypes, no significant differences were found on P53 expression status (P = 0.356) or rs17849071 polymorphism (T>G) (P = 0.813). In conclusion, SNP rs17849071 GT+GGgenotype was inversely associated with P53 protein accumulation in BCa samples. Studies with larger sample size focusing on exploring the relationship of rs17849071 polymorphisms, P53 accumulation, P53 mutations, and PIK3CA amplification might be needed.
引用
收藏
页数:6
相关论文
共 31 条
  • [1] Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer
    Astanehe, Arezoo
    Arenillas, David
    Wasserman, Wyeth W.
    Leung, Peter C. K.
    Dunn, Sandra E.
    Davies, Barry R.
    Mills, Gordon B.
    Auersperg, Nelly
    [J]. JOURNAL OF CELL SCIENCE, 2008, 121 (05) : 664 - 674
  • [2] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [3] p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer
    Berns, EMJJ
    Klijn, JGM
    van Putten, WLJ
    de Witte, HH
    Look, MP
    Gelder, MEM
    Willman, K
    Portengen, H
    Benraad, TJ
    Foekens, JA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 121 - 127
  • [4] HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer
    Berry, DA
    Muss, HB
    Thor, AD
    Dressler, L
    Liu, ET
    Broadwater, G
    Budman, DR
    Henderson, IC
    Barcos, M
    Hayes, D
    Norton, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3471 - 3479
  • [5] Caffo O, 1996, CLIN CANCER RES, V2, P1591
  • [6] Mutation of the PIK3CA gene in ovarian and breast cancer
    Campbell, IG
    Russell, SE
    Choong, DYH
    Montgomery, KG
    Ciavarella, ML
    Hooi, CSF
    Cristiano, BE
    Pearson, RB
    Phillips, WA
    [J]. CANCER RESEARCH, 2004, 64 (21) : 7678 - 7681
  • [7] Gaikwad SM, 2012, AM J NUCL MED MOLEC, V2, P418
  • [8] Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
    Goldhirsch, A.
    Winer, E. P.
    Coates, A. S.
    Gelber, R. D.
    Piccart-Gebhart, M.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (09) : 2206 - 2223
  • [9] Accumulation of p53 Determined by Immunohistochemistry as a Prognostic Marker in Node Negative Breast Cancer; Analysis According to St Gallen Consensus and Intrinsic Subtypes
    Jung, So-Youn
    Jeong, Junsoo
    Shin, Seung Ho
    Kwon, Youngmee
    Kim, Eun-A.
    Ko, Kyoung Lan
    Shin, Kyung Hwan
    Ro, Jungsil
    Lee, Keun Seok
    Park, In Hae
    Lee, Seeyoun
    Kim, Seok Won
    Kang, Han-Sung
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (03) : 207 - 211
  • [10] Identification of Novel Gene Amplifications in Breast Cancer and Coexistence of Gene Amplification with an Activating Mutation of PIK3CA
    Kadota, Mitsutaka
    Sato, Misako
    Duncan, Beverly
    Ooshima, Akira
    Yang, Howard H.
    Diaz-Meyer, Natacha
    Gere, Sheryl
    Kageyama, Shun-Ichiro
    Fukuoka, Junya
    Nagata, Takuya
    Tsukada, Kazuhiro
    Dunn, Barbara K.
    Wakefield, Lalage M.
    Lee, Maxwell P.
    [J]. CANCER RESEARCH, 2009, 69 (18) : 7357 - 7365